Combined colistin and rifampicin therapy for carbapenem-resistant Acinetobacter baumannii infections: clinical outcome and adverse events
- 1 August 2005
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 11 (8) , 682-683
- https://doi.org/10.1111/j.1469-0691.2005.01198.x
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibioticClinical Microbiology & Infection, 2005
- Interactions of colistin and rifampin on multidrug-resistant Acinetobacter baumanniiDiagnostic Microbiology and Infectious Disease, 2001
- Evaluation of the activities of two-drug combinations of rifampicin, polymyxin B and ampicillin/sulbactam against Acinetobacter baumannii.Journal of Antimicrobial Chemotherapy, 1998
- In-vitro activity of the combination of colistin and rifampicin against multidrug-resistant strains of Acinetobacter baumannii [published erratum appears in J Antimicrob Chemother 1998 Sep;42(3):413]Journal of Antimicrobial Chemotherapy, 1998